Such a delay leads to high levels of interferon expression in severely infected patients but does not reduce viral load; meanwhile, IFN pretreatment can significantly reduce viral infection levels, suggesting that drugs that can boost IFN production may be an effective option for early treatment of SARS-CoV-2 (Park and Iwasaki, 2020). Here, IFNA1 is linked to viral infectious disease.